Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Mauri

Showing results (61-70 of 335) with videos related to

Pageof 34
Sort By:
Lancet (London, England)|March 15, 2018
Bioresorbable polymer drug-eluting stents - Authors' replyDavid E Kandzari, Laura Mauri, Jacques J Koolen, et al.
Circulation|July 14, 2004
Coronary artery spatial distribution of acute myocardial infarction occlusionsJohn C Wang, Sharon-Lise T Normand, Laura Mauri, et al.
Journal of Lipid Research|December 25, 2019
Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseasesSara Grassi, Paola Giussani, Laura Mauri, et al.
Lancet (London, England)|June 13, 2015
Dual antiplatelet therapy duration and mortality - Authors' replyRobert W Yeh, Sammy Elmariah, Gheorghe Doros, et al.
Progress in Molecular Biology and Translational Science|May 12, 2018
Gangliosides in Membrane OrganizationSandro Sonnino, Elena Chiricozzi, Sara Grassi, et al.
Clinical Cardiology|March 28, 2014
Evolving antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: results from a survey among US cardiologistsMoshe Vardi, Marcella Debidda, Deepak L Bhatt, et al.
Glycoconjugate Journal|February 20, 2004
Synthesis of radioactive and photoactivable ganglioside derivatives for the study of ganglioside-protein interactionsLaura Mauri, Simona Prioni, Nicoletta Loberto, et al.
JACC. Cardiovascular Interventions|February 5, 2010
Safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: 12-month data from the E-Five registryChaim Lotan, Ian T Meredith, Laura Mauri, et al.
The American Journal of Cardiology|August 20, 2013
One-year outcomes of percutaneous coronary intervention with the 38-mm Resolute zotarolimus-eluting stentMichael Lee, Shirish Hiremath, Robaayah Zambahari, et al.
Journal of Interventional Cardiology|August 29, 2013
Real-world safety and effectiveness outcomes of a zotarolimus-eluting stent: final 3-year report of the RESOLUTE International studyJorge A Belardi, Petr Widimský, Franz-Josef Neumann, et al.
Pageof 34

Showing results (61-70 of 335) with videos related to

Sort By:
Pageof 34
Lancet (London, England)|March 15, 2018
Bioresorbable polymer drug-eluting stents - Authors' replyDavid E Kandzari, Laura Mauri, Jacques J Koolen, et al.
Circulation|July 14, 2004
Coronary artery spatial distribution of acute myocardial infarction occlusionsJohn C Wang, Sharon-Lise T Normand, Laura Mauri, et al.
Journal of Lipid Research|December 25, 2019
Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseasesSara Grassi, Paola Giussani, Laura Mauri, et al.
Lancet (London, England)|June 13, 2015
Dual antiplatelet therapy duration and mortality - Authors' replyRobert W Yeh, Sammy Elmariah, Gheorghe Doros, et al.
Progress in Molecular Biology and Translational Science|May 12, 2018
Gangliosides in Membrane OrganizationSandro Sonnino, Elena Chiricozzi, Sara Grassi, et al.
Clinical Cardiology|March 28, 2014
Evolving antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: results from a survey among US cardiologistsMoshe Vardi, Marcella Debidda, Deepak L Bhatt, et al.
Glycoconjugate Journal|February 20, 2004
Synthesis of radioactive and photoactivable ganglioside derivatives for the study of ganglioside-protein interactionsLaura Mauri, Simona Prioni, Nicoletta Loberto, et al.
JACC. Cardiovascular Interventions|February 5, 2010
Safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: 12-month data from the E-Five registryChaim Lotan, Ian T Meredith, Laura Mauri, et al.
The American Journal of Cardiology|August 20, 2013
One-year outcomes of percutaneous coronary intervention with the 38-mm Resolute zotarolimus-eluting stentMichael Lee, Shirish Hiremath, Robaayah Zambahari, et al.
Journal of Interventional Cardiology|August 29, 2013
Real-world safety and effectiveness outcomes of a zotarolimus-eluting stent: final 3-year report of the RESOLUTE International studyJorge A Belardi, Petr Widimský, Franz-Josef Neumann, et al.
Pageof 34